ArticleCureus2024
Efficacy of Radio Electric Asymmetric Conveyor (REAC) Anti-inflammatory, Circulatory, and Metabolic Optimization Treatments for Managing Chronic Pain, Edema, and Lipodystrophy in Post-menopausal Women: A Case Series.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- REAC RGN-AR treatment modulates adipogenic differentiation in adipose tissue-derived stem cells.Scientific reports · 2026Article
- Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic pain, edema, and lipodystrophy are common issues in post-menopausal women, often linked to hormonal imbalances, metabolic dysfunctions, and chronic inflammation. Traditional treatments, such as hormone replacement therapy (HRT) and aesthetic procedures, frequently provide limited and temporary relief. This case series evaluates the effectiveness of radio electric asymmetric conveyor (REAC) technology specifically, the anti-cellulite treatment (ACT), circulatory optimization (CO), and metabolic optimization (MO) protocols in four post-menopausal women presenting with these conditions. Each patient underwent 18 sessions of ACT, CO, and MO protocols using the REAC Bio-Enhancer Neuro-Enhancer (BENE) 110 medical device (ASMED Srl, Scandicci Florence, Italy), with asymmetric conveyor probes (ACPs) symmetrically positioned on the quadriceps. The ACT protocol targeted skin and subcutaneous tissue biomechanical properties, the CO protocol focused on enhancing circulation and reducing edema, and the MO protocol aimed to restore metabolic balance. The results demonstrated significant improvements across all patients, with reductions in pain (9/10 to 3/10), edema, and lipodystrophy, as well as enhanced mood and overall well-being. Objective measures, such as reductions in thigh circumference and improvements in inflammatory markers, further supported the systemic benefits of REAC ACT, CO, and MO treatments. These findings suggest that REAC protocols offer a comprehensive and effective non-invasive treatment for chronic inflammatory and metabolic conditions in post-menopausal women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.